1. Pretty much every drug that enters human trials has already...

1. Pretty much every drug that enters human trials has already been shown to be safe and effective in animal tests

Based on this logic, BIT225 did not necessitate further testing because it was already proven to be safe for humans. The latest Ann informed stakeholders that BIT225 has a 99.99% efficacy against covid infected mice.

2. Unfortunately the vast majority of drugs that do enter human trials end up failing, despite having been successful in animal models.

So again setting your extremely strong bias aside, its not worth furthering the possibility of success even at 99.99% efficacy just at the off chance of failure???

What would RAC do in a situation like that shareman?